4.2 Article

Study of the osteoprotegerin/receptor activator of nuclear factor-kB ligand system association with inflammation and atherosclerosis in systemic sclerosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

The role of cytokines in inflammatory bone loss

Pedro P. C. Souza et al.

IMMUNOLOGICAL INVESTIGATIONS (2013)

Review Rheumatology

The role of RANK ligand/osteoprotegerin in rheumatoid arthritis

Piet Geusens

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2012)

Article Rheumatology

Atherosclerosis in Systemic Sclerosis A Systematic Review and Meta-Analysis

Karen Au et al.

ARTHRITIS AND RHEUMATISM (2011)

Review Geriatrics & Gerontology

Vascular aging: From molecular mechanism to clinical significance

Motoji Sawabe

GERIATRICS & GERONTOLOGY INTERNATIONAL (2010)

Article Cardiac & Cardiovascular Systems

Osteoprotegerin as a Predictor of Coronary Artery Disease and Cardiovascular Mortality and Morbidity

Shreenidhi M. Venuraju et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)

Article Rheumatology

Subclinical atherosclerosis in scleroderma patients

N. Tsifetaki et al.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2010)

Review Cardiac & Cardiovascular Systems

Osteoprotegerin, vascular calcification and atherosclerosis

Ann Van Campenhout et al.

ATHEROSCLEROSIS (2009)

Article Rheumatology

Atherosclerosis in autoimmune diseases

Eiji Matsuura et al.

Current Rheumatology Reports (2009)

Article Endocrinology & Metabolism

The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: a systematic literature review

Mads Nybo et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)

Article Rheumatology

Circulating Osteoprotegerin and Soluble RANK Ligand in Systemic Sclerosis

Andrea Dovio et al.

JOURNAL OF RHEUMATOLOGY (2008)

Review Endocrinology & Metabolism

The role of receptor activator of nuclear factor-κB (RANK)/RANK ligand/osteoprotegerin:: Clinical implications

Damaris Vega et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)

Article Cardiac & Cardiovascular Systems

Soluble receptor activator of nuclear factor-κB ligand and risk for cardiovascular disease

Stefan Kiechl et al.

CIRCULATION (2007)

Review Medicine, General & Internal

Systemic sclerosis: hypothesis-driven treatment strategies

Christina Charles et al.

LANCET (2006)

Article Cardiac & Cardiovascular Systems

Pathogenesis of atherosclerosis

E Falk

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)

Review Cardiac & Cardiovascular Systems

Accelerated atherosclerosis in autoimmune rheumatic diseases

Y Shoenfeld et al.

CIRCULATION (2005)

Review Medicine, General & Internal

Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis

SA Jimenez et al.

ANNALS OF INTERNAL MEDICINE (2004)

Review Cardiac & Cardiovascular Systems

Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin

P Collin-Osdoby

CIRCULATION RESEARCH (2004)

Article Rheumatology

Carotid and femoral arterial wall mechanics in scleroderma

KS Cheng et al.

RHEUMATOLOGY (2003)

Article Hematology

Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques

CR Dhore et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)

Review Genetics & Heredity

Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology

LC Hofbauer et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2001)

Article Endocrinology & Metabolism

Bone loss and the progression of abdominal aortic calcification over a 25 year period: The Framingham Heart Study

DP Kiel et al.

CALCIFIED TISSUE INTERNATIONAL (2001)

Article Rheumatology

Macrovascular disease and systemic sclerosis

ML Ho et al.

ANNALS OF THE RHEUMATIC DISEASES (2000)